SP3 and breast carcinoma: For breast cancer, of the six predicted candidates (PRKCQ, ARAF, MAPK14, BRMS1, CDC42BPA, SP3), three (PRKCQ, ARAF, MAPK14) are members of at least one KEGG cancer relevant pathway.